Polymersomes, nanoscopic polymer vesicles self-assembled from synthetic block copolymers, have shown great promise in biomedical applications from drug delivery to artificial organelles.^[@ref1]^ Polymersomes display enhanced stability and membrane integrity under a wide range of conditions when compared to liposomes, frequently used in nanomedical systems, due to their thicker membranes.^[@ref2]^ Polymersome morphology can be controlled by copolymer composition and subsequently re-engineered in response to chemical or physical stimuli such as pH, osmotic pressure, temperature, or magnetic fields.^[@ref3]^ The importance of gaining control over the size and shape of nanoparticles is essential to directing their function *in vivo*.^[@ref4]^ While spherical polymersomes have shown to be successful candidates for some applications in a biological context,^[@ref5]^ the ability to transform their morphology can lead to new biomedical opportunities such as targeted drug delivery.^[@cit4f]^

For example, it has been shown that high-aspect ratio structures lead to enhanced specific accumulation and reduced nonspecific adhesion to cells.^[@ref6]^ Elongated nanoparticles interact with cells via distinct mechanisms, leading to enhanced uptake, in a similar fashion to the uptake of rod-like bacteria by nonphagocytotic cells.^[@ref7]^ Moreover, the unique ability of tubular morphologies, in contrast to spheres, to interact with the immune system through multivalency is an exciting prospect for the development of artificial antigen-presenting cells.^[@cit4g]^ However, up to this point the bulk of research toward engineering elongated polymeric vesicles has focused on nonbiocompatible polymers. For example, tubular nanostructures have been reported, with shape transformation accomplished by using chemical stimuli such as the covalent introduction of a redox cleavable cross-linker^[@ref8]^ or by swelling the membrane with lipids or cholesterol.^[@ref9]^ However, the utility of such methodologies is limited by their nonbiodegradable components or lack of structural control. It is therefore of critical importance to develop new methodologies for the generation of well-defined, elongated polymersomes utilizing biodegradable polymers. Biodegradable copolymers have shown excellent promise in the development of biocompatible nanomaterials for medical applications.^[@cit4f],[@ref10]^ Biodegradable nanotubes can therefore be directly implemented in nanomedical research due to their inherent biocompatibility.^[@ref11]^

Here, we present a methodology for the formation of functional, polymeric nanotubes from biodegradable polymersomes comprising poly(ethylene glycol)-*b*-poly([d]{.smallcaps},[l]{.smallcaps}-lactide) (PEG-PDLLA). Poly(lactides) have established utility in biomedical engineering due to their biocompatibility and degradation behavior, which has been shown to vary between days or weeks, depending on the conditions employed.^[@ref12]^ Furthermore, the formation of polymersomes from PEG-PDLLA block copolymers has previously been reported.^[@cit12a]^ Herein, we demonstrate that spherical polymersomes comprising PEG-PDLLA block copolymers can be transformed into well-defined nanotubes by exposure to hypertonic conditions, and thereby osmotic pressure, at low temperature. In this way, nanotubes of different lengths are controllably obtained by varying the electrolyte concentration. Moreover, such nanotubes can readily be functionalized through incorporation of hydrophobic drugs or via surface modification with proteins utilizing bio-orthogonal "click" chemistry.

Previously we reported the osmotically induced shape transformation of poly(ethylene glycol)-*b*-poly(styrene) (PEG-PS) polymersomes into bowl-shaped stomatocytes through deflation of the inner volume and membrane indentation.^[@ref13]^ This shape was maintained because PS in the membrane has a high glass transition temperature, which provides the necessary membrane rigidity at room temperature to prevent structural relaxation toward a spherical morphology. In order to understand in more detail the nature of the shape transformation that occurs when spherical polymersomes are exposed to hypertonic conditions, it is necessary to consider the bending energy (*E*~b~) that can be described by [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}:^[@ref14],[@ref15]^

[Eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"} allows us to describe the energetic state of a polymersomal membrane as a function of 3 parameters: the bending rigidity (*k*), the mean surface curvature (*C*), and the spontaneous curvature (*C*~0~). The bending rigidity (*k*) is dictated by the chemical properties of the membrane (polymer composition and length) alongside environmental factors (temperature and solvent composition). The mean surface curvature (*C*) describes the degree of curvature at different positions on the membrane and is contingent upon the shape. In contrast to *C*, the spontaneous curvature (*C*~0~) is not a consequence of the shape; rather, it arises from asymmetry in copolymer conformation between the inner and outer surfaces and is therefore sensitive to the membrane microenvironment. From [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"} we understand that the effect of *C*~0~ is to either reduce or increase *E*~b~ for a given morphology and, as such, can be used to gain control over the shape transformation process.^[@ref14]^ Under the influence of osmotic pressure, which can be orders of magnitude greater than *E*~b~, as a spherical polymersome undergoes reduction in volume there are 2 energetic pathways that can be taken. Such deflation can proceed via prolates (toward tubes) or oblates (toward discs and stomatocytes) as a result of the minimization of *E*~b~, with the determining factor being *C*~0~. Without significant contribution from the effect of *C*~0~, the prolate pathway has a lower energetic profile, however, a positive or negative contribution of *C*~0~ would favor either prolates or oblates, respectively.^[@ref15]^ With this in mind, it is clear that finding a suitable biodegradable replacement for poly(styrene), which is sufficiently rigid while tending toward prolates and tubes rather than discoidal structures, is a challenging task.

Shape transformations of self-assembled structures using most common poly(esters) and poly(carbonates), even with careful tuning of conditions, are extremely challenging due to their amorphous (low *T*~g~) or crystalline (high *T*~m~) character. However, atactic polylactide, synthesized from a mixture of lactide isomers, possesses a *T*~g~ above 20 °C (as opposed to the isotactic form that is highly crystalline) and is therefore an excellent candidate for the formation of biodegradable polymersomes and their shape transformed counterparts.^[@ref16]^ PEG-PDLLA copolymers were synthesized by ring-opening polymerization (ROP) with the organic base 1,8-diazabicycloundec-7-ene (DBU) as a catalyst, according to previous literature ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a).^[@ref17]^ The reaction progress and the composition of the final product were calculated from the NMR spectra ([Figures S1 and S2](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)) with the resulting copolymers having PDI values of \<1.1 ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)). Two copolymers were synthesized, PEG~22~-*b*-PDLLA~45~ (*M*~w~ ≈ 7.5 kDa) and PEG~44~-*b*-PDLLA~90~ (*M*~w~ ≈ 14.9 kDa), both comprising ∼13 wt % PEG. Differential scanning calorimetry (DSC) data confirmed that the *T*~g~ values for PEG~22~-PDLLA~45~ and PEG~44~-PDLLA~90~ were ∼26 and 30 °C, respectively ([Figure S4](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)).

![Schematic outlining (a) the organobase-catalyzed synthesis of PEG-PDLLA and (b) the osmotically induced shape transformation of spherical polymersomes into nanotubes.](ja-2016-039849_0001){#fig1}

Assembly tests using PEG-PDLLA were conducted using an established method for polymersome formation via solvent switch, whereby a solution of block copolymer in organic solvent (4:1, THF:dioxane) was diluted by water (up to 50% v/v at 1 mL/h, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b).^[@ref18]^ Interestingly, the longer copolymer PEG~44~-PDLLA~90~ yielded micelles (spherical and rods, [Figure S5a](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)), whereas PEG~22~-PDLLA~45~ yielded polymersomes with a hydrodynamic radius (*R*~h~) ≈ 165 nm and a 15 nm thick membrane ([Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a and [S5b--d](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)). In order to transform the spherical polymersomes into nanotubes, the plasticized dispersion was dialyzed against aqueous solutions with varying salt concentration (5, 10, and 50 mM) at 4 °C so that the glassiness of the membrane was maintained after the main part of organic solvent was removed. It was observed that after overnight dialysis against 5 mM NaCl the polymersomes had partially transformed into prolate structures, and a mixture of morphologies was observed ([Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b and [S6a](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)). By comparison, dialysis against higher \[NaCl\] (10 and 50 mM) resulted in the predominant formation of elongated (prolate) nanotubes of increasing length ([Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}c,d and [S6b,c](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)). Interestingly, polymersome dialysis against 100 mM NaCl resulted in the formation of elongated ribbons, identified as collapsed nanotubes ([Figure S6d](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)). Conversely, when dialyzing the spherical polymersomes at 25 °C, no shape transformation was observed while at 30 °C collapsed structures were obtained ([Figures S6e-f](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)), highlighting the importance of polymer rigidity for establishing and maintaining the shape transformation.

![Cryo-TEM images following the shape transformation of PEG~22~-PDLLA~45~ from (a) spherical polymersomes into elongated nanotubes under the influence of osmotic pressure by dialysis, as a function of \[NaCl\]; (b) 5, (c) 10, and (d) 50 mM. All scale bars = 500 nm.](ja-2016-039849_0002){#fig2}

Nanotubes formed using dialysis against 10 mM NaCl were on average shorter, with average dimensions (length × width) of 110 × 800 nm, whereas dialysis against 50 mM NaCl yielded longer tubes of 90 × 1040 nm ([Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}c,d, [S6b,c, and S7](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)). Crucially, these dimensions correspond to average surface areas of ∼3 × 10^6^ nm^2^, similar to that of the original polymersomes, however, the internal volume significantly decreased by 39 and 51% for the samples dialyzed against 10 and 50 mM NaCl, respectively ([Table S1](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)). This highlights that increased osmotic pressure results in nanotube elongation due to the geometrical constraint of surface area during osmosis and concomitant reduction of internal volume. Asymmetric flow field-flow fractionation (AF4, settings in [Table S2](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)), in combination with static and dynamic light scattering, were used in order to gain a quantitative understanding of the shape transformation from vesicles to tubes. Comparing the radius of gyration (*R*~g~) to the hydrodynamic radius (*R*~h~) gives information on particle shape where values of *R*~g~/*R*~h~ for spheres are ≤1 and for prolates (rod-like shapes) are \>1.36.^[@ref19]^ Elution profiles, with corresponding values for *R*~g~, clearly showed that the spherical PEG-PDLLA polymersomes have a uniform ratio value near to 1 (hollow spheres), whereas the nanotubes have an average value of 1.5 with all values \>1.3, which quantitatively demonstrates that the predominant morphology is that of tubes ([Figure S8](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)). Light scattering and cryo-TEM were used to confirm that nanotubes, once formed, are stable under increased temperature and salt concentration, as would be encountered under physiological conditions, which is vital for application toward biomedical research. Indeed, tubular morphology was sustained after dialysis against PBS, with both the *R*~h~ and scattering intensity remaining constant during heating to 40 °C, due to lack of osmotic pressure ([Figure S9](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)).

Under hypertonic conditions, polymersomes comprising PEG~22~-PDLLA~45~ deflate into nanotubes rather than stomatosomal or nested structures, which are more commonly encountered.^[@ref13],[@ref20]^ As has already been discussed, the contribution of *C*~0~ is a deciding factor for the direction of shape transformations. In our previous work using PEG-PS polymersomes, a less permeable PS membrane and longer PEG chains at the surface led to a negative *C*~0~, which induced the formation of oblates, stomatocytes and nested vesicles.^[@ref13],[@cit14b]^ In comparison, for the shape transformation of PEG-PDLLA polymersomes, increasing the \[NaCl\] during dialysis not only results in greater volume reduction but also influences the transformation pathway. Dialyzing polymersomes against 5 mM NaCl resulted in the formation of a population of heterogeneous morphologies, dominated by prolates, which is unsuitable for quantification ([Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b and [S6a](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)). However, increasing the \[NaCl\] to 10 and 50 mM gave a significant improvement in the quantity (and quality) of prolate structures, concurrently lowering the percentage of oblate morphologies to ∼10 and 4%, respectively ([Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}c,d and [S6b](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)). Interestingly, dialysis under increased osmotic pressure (100 mM NaCl) led to the formation of nanotubes that underwent total collapse due to outflow of all internal solvent molecules during the shape transformation process. These results suggest that not only does NaCl contribute toward solution osmolarity, which drives volume reduction and elongation, but it also contributes toward a positive *C*~0~, promoting the formation of prolates and tubes. Although the physical origins of *C*~0~ are not well documented, it is evident that it arises from a mismatch between the external and internal membrane surfaces. Such a mismatch is accentuated by chemical differences between external and internal environments, which is the case in the current situation. Although it is beyond the scope of the present work, these findings warrant further investigation into the unique properties of PEG-PDLLA in order to develop experimental insight into the contribution of *C*~0~ in shape transformations.

In order to establish the functional capacity of PEG-PDLLA nanotubes, experiments were conducted to demonstrate biomolecular labeling ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a--c) and drug loading ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}d--f). Biomolecular labeling of nanoparticles is an important procedure by which biological activity can be introduced to the surface through covalent modification with antibodies or antigens in order to provide site-selective specificity in cellular uptake or to stimulate specific immune responses.^[@ref21]^ It is therefore important to demonstrate that the nanotubes can be modified with surface-bound biomolecules, which retain their native function after attachment. For this purpose, enhanced green fluorescent protein (eGFP) containing the clickable unnatural amino acid bicyclo\[6.1.0\]nonyne-[l]{.smallcaps}-lysine (BCN-lys) was expressed and purified (eGFP^BCN^, [Figures [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a and [S10](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)). Azido-modified copolymer (N~3~-PEG~75~-PDLLA~45~) was introduced into the nanotubes at different amounts (2 and 5 wt %) to demonstrate that control over the density of biomolecular labeling can be accomplished through simple formulation. Flow cytometry and confocal microscopy were used to confirm successful labeling of eGFP onto the nanotube, with a positive signal indicating that the tethered eGFP maintains its native structure ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}).^[@ref22]^ The stability of eGFP modified N~3~-nanotubes was confirmed by cryo-TEM ([Figure S11a](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)). With flow cytometry the N~3~-nanotubes showed increases in their fluorescent signal upon increasing the concentration of eGFP^BCN^ in the reaction mixtures from an equimolar amount to a 3-fold excess ([Figures [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}b and [S11c](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)) as well as by increasing the total N~3~-copolymer content from 2 to 5 wt % ([Figure S11d](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)). It was furthermore investigated if hydrophobic cargo could be loaded in the polymer membrane without undesired effects on nanotube formation, at levels comparable to literature.^[@ref23]^ To this end, PEG-PDLLA nanotubes were prepared in the presence of 2 and 5 wt % of hydrophobic doxorubicin (DOX), which was dissolved into the organic solvent phase and then became incorporated into the copolymer membrane. As was confirmed by cryo-TEM, DOX did not impede the subsequent shape transformation ([Figure S11b](http://pubs.acs.org/doi/suppl/10.1021/jacs.6b03984/suppl_file/ja6b03984_si_001.pdf)). Flow cytometry was used to confirm nanotube fluorescence, which increased with greater amounts of DOX, although it is likely that 5 wt % is above the capacity for this system as the signal did not greatly increase in comparison with 2 wt % loading ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}e). Specific association of the drug with the nanotubes was confirmed using confocal microscopy ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}f).

![(a) Schematic outlining the covalent modification of azide-modified nanotubes using eGFP^BCN^, (b) flow cytometry data for eGFP modification of 5% azido nanotubes using an equimolar (ii) or a 3-fold excess (iii) of eGFP^BCN^ compared to unmodified tubes (i) and (c) confocal visualization of green-fluorescent nanotubes. (d) Schematic outlining the loading of nanotubes with fluorescent DOX, (e) flow cytometry data of nanotubes loaded with 2 (ii) and 5 (iii) wt % DOX compared to unloaded tubes (i) and (f) confocal visualization of DOX-loaded nanotubes (5 wt % preparation). All scale bars = 5 μm.](ja-2016-039849_0003){#fig3}

In summary, we have presented the synthesis of biodegradable PEG-PDLLA copolymers that spontaneously assemble into spherical polymersomes. These biodegradable polymersomes can then undergo shape transformation into nanotubes upon dialysis under hypertonic conditions, with increasing \[NaCl\] leading to both structural enrichment and elongation. Such well-defined nanoparticles, which can be easily functionalized, are of great interest for biomedical research where nanoscopic control over size and shape is highly valuable.
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